Clinical Trial Update: A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating GR1014 Cutaneous Gel to prevent radiodermatitis in patients undergoing radiation therapy for breast cancer. The trial is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Radiodermatitis

Drugs mentioned

• GR1014 Cutaneous Gel

Snippet

Sponsor: Graegis Pharmaceuticals Ltd | Conditions: Radiodermatitis; Acute | Phase 2 | Status: ACTIVE_NOT_RECRUITING